8.3. Analysis.
Comparison 8: Continuous aztreonam (AZLI)/tobramycin (TIS) versus intermittent tobramycin (TIS), Outcome 3: Need for additional antibiotics for an exacerbation
Comparison 8: Continuous aztreonam (AZLI)/tobramycin (TIS) versus intermittent tobramycin (TIS), Outcome 3: Need for additional antibiotics for an exacerbation